Benefits of neoadjuvant therapy compared with adjuvant chemotherapy for the survival of patients with HER2-positive breast cancer: A retrospective cohort study at FUSCC

Autor: Zheng, Shuyue, Li, Lun, Chen, Ming, Yang, Benlong, Chen, Jiajian, Liu, Guangyu, Shao, Zhimin, Wu, Jiong
Zdroj: In The Breast June 2022 63:177-186
Databáze: ScienceDirect